Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHAMBERLAIN, M. A.
Right arrow Articles by KEENAN, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHAMBERLAIN, M. A.
Right arrow Articles by KEENAN, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1976 British Society for Rheumatology

other

THE EFFECT OF LOW DOSES OF PREDNISOLONE COMPARED WITH PLACEBO ON FUNCTION AND ON THE HYPOTHALAMIC PITUITARY ADRENAL AXIS IN PATIENTS WITH RHEUMATOID ARTHRITIS

M. ANNE CHAMBERLAIN* and J. KEENAN{dagger}

Arthur Stanley House, The Middlesex Hospital, and the Courtauld Institute London, W1

A double-blind trial of prednisolone in patients with rheumatoid arthritis using doses of zero, 3 mg and 5 mg is reported. Patients on a dose of 3 mg derived little sustained benefit but subjects on the higher dose showed some improvement which did not last more than two years. Mild suppression of the hypothalamo-pituitary-adrenal axis occurred in both steroid-treated groups.

*Present address: Department of Rheumatology and Rehabilitation, The General Infirmary, Leeds.

{dagger}Present address: Department of Chemical Pathology, King's College Hospital, London


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.